Moderna stock surged Tuesday after the Centers for Disease Control and Prevention noted a two-week spike in positive Covid tests. Moderna led S&P 500 gainers Tuesday, a day after the first bird ...

(Nasdaq: AXON). The Nasdaq-100 Index® is composed of 100 of the largest non-financial c CAMBRIDGE, MA / ACCESSWIRE / November 25, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its ...

Moderna, a leader in mRNA medicine, developed one of the earliest COVID-19 vaccines, with Spikevax being its first commercial product. The company's mRNA platform enables the development of ...

The halt was triggered by an “imbalance,” the FDA said, in cases of severe lower respiratory tract infections (LRTIs) in children in a phase 1 trial of two Moderna RSV vaccines. One of the ...

Moderna has said it will open a new R&D and manufacturing facility in the UK which could lead to improved access by NHS patients to mRNA-based vaccines and drug treatments. The facility is the ...

In September, Moderna unveiled key updates at its annual R&D Day, spotlighting its mRNA-based pipeline and revised financial plans. The company has witnessed a decline in its only approved ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage non ...

Infants are among the most vulnerable when it comes to RSV—but there's still no vaccination for them. A pediatric vaccine for respiratory syncytial virus (RSV) is proving to be elusive ...

As human cases of avian influenza slowly tick up amid the outbreak in U.S. dairy cattle, the Centers for Disease Control and Prevention (CDC) and Moderna have teamed up to design an mRNA vaccine ...

A pediatric vaccine for respiratory syncytial virus (RSV) is proving to be elusive, according to news from the U.S. Food and Drug Administration. RSV is a highly contagious, common respiratory ...